Nebenwirkungen · Actraphane
Actraphane 50 Penfill 100 international units/ml suspension for injection in cartridge. · Abschnitt 4.8 · PDF-Seite 17
HOS-111131 · Präparat HOS-093449
At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur. These reactions are usually of a transitory nature. Fast improvement in blood glucose control may be associated with acute painful neuropathy, which is usually reversible. Intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy, while long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-02-02T17:15:00Z · SHA-256 26dbeb74a547c17fa19179da3b8be82ef51aad193f03783398c99de5d9352ec6 · Passage 43bf1d5e3dce452b353a7adcf0ab3e439ffecaec389091f057f0ef1b1ad2a099 · Zeichen 282–906 im Abschnitt